Search Results - "Cascallò, Manel"
-
1
A Phase 1 Trial of Oncolytic Adenovirus ICOVIR-5 Administered Intravenously to Cutaneous and Uveal Melanoma Patients
Published in Human gene therapy (01-03-2019)“…Oncolytic viruses represent a unique type of agents that combine self-amplification, lytic, and immunostimulatory properties against tumors. A local and…”
Get more information
Journal Article -
2
Safety and efficacy of VCN-01, an oncolytic adenovirus combining fiber HSG-binding domain replacement with RGD and hyaluronidase expression
Published in Clinical cancer research (15-03-2015)“…Tumor targeting upon intravenous administration and subsequent intratumoral virus dissemination are key features to improve oncolytic adenovirus therapy…”
Get full text
Journal Article -
3
Hyaluronidase Expression by an Oncolytic Adenovirus Enhances Its Intratumoral Spread and Suppresses Tumor Growth
Published in Molecular therapy (01-07-2010)“…Successful virotherapy requires efficient virus spread within tumors. We tested whether the expression of hyaluronidase, an enzyme which dissociates the…”
Get full text
Journal Article -
4
Therapeutic targeting of the RB1 pathway in retinoblastoma with the oncolytic adenovirus VCN-01
Published in Science translational medicine (23-01-2019)“…Retinoblastoma is a pediatric solid tumor of the retina activated upon homozygous inactivation of the tumor suppressor VCN-01 is an oncolytic adenovirus…”
Get more information
Journal Article -
5
Phase I, multicenter, open-label study of intravenous VCN-01 oncolytic adenovirus with or without nab-paclitaxel plus gemcitabine in patients with advanced solid tumors
Published in Journal for immunotherapy of cancer (01-03-2022)“…VCN-01 is an oncolytic adenovirus (Ad5 based) designed to replicate in cancer cells with dysfunctional RB1 pathway, express hyaluronidase to enhance virus…”
Get full text
Journal Article -
6
A pRb-responsive, RGD-modified, and Hyaluronidase-armed Canine Oncolytic Adenovirus for Application in Veterinary Oncology
Published in Molecular therapy (01-05-2014)“…Human and canine cancer share similarities such as genetic and molecular aspects, biological complexity, tumor epidemiology, and targeted therapeutic…”
Get full text
Journal Article -
7
The Oncolytic Adenovirus VCN-01 as Therapeutic Approach Against Pediatric Osteosarcoma
Published in Clinical cancer research (01-05-2016)“…Osteosarcoma is the most common malignant bone tumor in children and adolescents. Despite aggressive chemotherapy, more than 30% of patients do not respond and…”
Get full text
Journal Article -
8
VCN-01 disrupts pancreatic cancer stroma and exerts antitumor effects
Published in Journal for immunotherapy of cancer (01-11-2021)“…BackgroundPancreatic ductal adenocarcinoma (PDAC) is characterized by dense desmoplastic stroma that limits the delivery of anticancer agents. VCN-01 is an…”
Get full text
Journal Article -
9
Adenovirus i-Leader Truncation Bioselected Against Cancer-associated Fibroblasts to Overcome Tumor Stromal Barriers
Published in Molecular therapy (01-01-2012)“…Tumor-associated stromal cells constitute a major hurdle in the antitumor efficacy with oncolytic adenoviruses. To overcome this biological barrier, an in…”
Get full text
Journal Article -
10
Characterization of the Antiglioma Effect of the Oncolytic Adenovirus VCN-01
Published in PloS one (01-01-2016)“…Despite the recent advances in the development of antitumor therapies, the prognosis for patients with malignant gliomas remains dismal. Therapy with…”
Get full text
Journal Article -
11
Minimal RB-responsive E1A Promoter Modification to Attain Potency, Selectivity, and Transgene-arming Capacity in Oncolytic Adenoviruses
Published in Molecular therapy (01-11-2010)“…Oncolytic adenoviruses are promising anticancer agents due to their ability to self-amplify at the tumor mass. However, tumor stroma imposes barriers difficult…”
Get full text
Journal Article -
12
Combined fiber modifications both to target α(v)β(6) and detarget the coxsackievirus-adenovirus receptor improve virus toxicity profiles in vivo but fail to improve antitumoral efficacy relative to adenovirus serotype 5
Published in Human gene therapy (01-09-2012)“…Achieving high-efficiency tumor targeting after systemic delivery is a considerable challenge facing oncolytic gene therapists. Efficient retargeting should be…”
Get more information
Journal Article -
13
Correction: Characterization of the Antiglioma Effect of the Oncolytic Adenovirus VCN-01
Published in PloS one (09-06-2016)“…[This corrects the article DOI: 10.1371/journal.pone.0147211.]…”
Get full text
Journal Article -
14
Ras-dependent oncolysis with an adenovirus VAI mutant
Published in Cancer research (Chicago, Ill.) (01-09-2003)“…Adenovirus synthesize proteins that interact with oncogene and tumor suppressor gene products to set the cell for virus replication. Mutant viruses defective…”
Get full text
Journal Article -
15
Adeno-associated virus enhances wild-type and oncolytic adenovirus spread
Published in Human gene therapy. Part B. Methods (01-12-2013)“…The contamination of adenovirus (Ad) stocks with adeno-associated viruses (AAV) is usually unnoticed, and it has been associated with lower Ad yields upon…”
Get more information
Journal Article -
16
Positive selection of gene-modified cells increases the efficacy of pancreatic cancer suicide gene therapy
Published in Molecular cancer therapeutics (01-11-2009)“…Thymidine kinase (TK)-mediated suicide gene therapy has been considered for the treatment of pancreatic cancer. However, despite a bystander effect, the…”
Get full text
Journal Article -
17
Anti-migratory and anti-angiogenic effect of p16 : A novel localization at membrane ruffles and lamellipodia in endothelial cells
Published in Angiogenesis (London) (01-12-2004)“…Recent evidence has established different functions for the tumor suppressor protein, p16(INK4A) aside from controlling the cell cycle. Here we report that…”
Get full text
Journal Article -
18
Enhancement of gemcitabine-induced apoptosis by restoration of p53 function in human pancreatic tumors
Published in Oncology (01-01-2005)“…Human pancreatic adenocarcinomas are highly resistant to conventional treatment modalities, specially to chemotherapy. Among the genes that modulate apoptosis…”
Get more information
Journal Article -
19
Adenovirus-mediated wt-p16 reintroduction induces cell cycle arrest or apoptosis in pancreatic cancer
Published in Cancer gene therapy (01-10-2001)“…Pancreatic cancer has long carried poor prognosis. The development of new therapeutic approaches is particularly urgent. Inactivation of the tumor-suppressor…”
Get full text
Journal Article -
20
Modulation of drug cytotoxicity by reintroduction of wild-type p53 gene (Ad5CMV-p53) in human pancreatic cancer
Published in Cancer gene therapy (01-04-2000)“…Chemotherapy does not significantly improve prognosis in pancreatic cancer. New therapeutical approaches involving p53 gene replacement appear to be very…”
Get full text
Journal Article